Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems.

Pulse Systems has recently announced the opening of a new East Coast Development Center facility in Marlborough, MA. Pulse Systems currently provides prototype and production support to customers worldwide from its facilities in Northern California.

Precigen commenced the build-out of the nearly 5,000 square foot manufacturing facility in 2018 to support gene therapy manufacturing. The good manufacturing practices (GMP) facility was designed with agility and control in mind, focusing on rapid manufacturing and the ability to scale production appropriately to meet early stage clinical trial needs.

Worldwide silicon wafer area shipments dropped 5.6 percent during the first quarter 2019 when compared to the fourth quarter 2018 and are now at their lowest level since the fourth quarter of 2017 after silicon wafer shipments for the most recent quarter declined 1 percent quarter-over-quarter, according to the SEMI Silicon Manufacturers Group (SMG) in its quarterly analysis of the silicon wafer industry.

The global Rubber glove market is set to grow at an exponential CAGR during the forecast period attributed to its increasing demand across several industrial applications. Rubber gloves are being used for several industrial and household purposes.

For the past few months, the clean room floor in High Bay 1 at NASA’s Jet Propulsion Laboratory in Pasadena, California, has been covered in parts, components and test equipment for the Mars 2020 spacecraft, scheduled for launch toward the Red Planet in July of 2020. But over the past few weeks, some of these components

Taking a cue from biological cells, researchers from MIT, Columbia University, and elsewhere have developed computationally simple robots that connect in large groups to move around, transport objects, and complete other tasks.

Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications and rare diseases through gene therapy, cell therapy, exosomes, novel molecules and combinations with existing pharmaceuticals, announced today that it has received funding from the Israeli Ministry of the Economy to build a gene therapy facility.

ThermoGenesis Corp, a private corporation owned by Cesca Therapeutics, and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced the construction and qualification of a new Class